Funding for this research was provided by:
National Institutes of Health (CA232130, CA008748, CA204441)
australian national health and medical research council (APP1072113)
Australian National Health and Medical Research Council (APP1136889)
Ruth L. Kirschstein fellowship (EB025050)
Received: 20 February 2020
Accepted: 8 April 2020
First Online: 14 May 2020
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: All of the authors have read and approved the manuscript and possible conflict of interests are disclosed.
: T.R. is shareholder of Summit Biomedical Imaging, LLC, and paid consultant for Theragnostics, Inc. J.G., P.D.d.S.F., G.F.K., J.S.L., and T.R. filed a patent surrounding the use of fluorophores with Hs1a and Hsp1a.